435 related articles for article (PubMed ID: 23729264)
1. Molecular fields in ligand discovery.
Gane PJ; Chan AW
Methods Mol Biol; 2013; 1008():479-99. PubMed ID: 23729264
[TBL] [Abstract][Full Text] [Related]
2. Structure-based virtual screening for novel ligands.
Pitt WR; Calmiano MD; Kroeplien B; Taylor RD; Turner JP; King MA
Methods Mol Biol; 2013; 1008():501-19. PubMed ID: 23729265
[TBL] [Abstract][Full Text] [Related]
3. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
[TBL] [Abstract][Full Text] [Related]
6. Application of support vector machine to three-dimensional shape-based virtual screening using comprehensive three-dimensional molecular shape overlay with known inhibitors.
Sato T; Yuki H; Takaya D; Sasaki S; Tanaka A; Honma T
J Chem Inf Model; 2012 Apr; 52(4):1015-26. PubMed ID: 22424085
[TBL] [Abstract][Full Text] [Related]
7. Biophysical methods in drug discovery from small molecule to pharmaceutical.
Holdgate G; Geschwindner S; Breeze A; Davies G; Colclough N; Temesi D; Ward L
Methods Mol Biol; 2013; 1008():327-55. PubMed ID: 23729258
[TBL] [Abstract][Full Text] [Related]
8. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
[TBL] [Abstract][Full Text] [Related]
9. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
Hoffer L; Renaud JP; Horvath D
J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
[TBL] [Abstract][Full Text] [Related]
10. Development of a rule-based method for the assessment of protein druggability.
Perola E; Herman L; Weiss J
J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
[TBL] [Abstract][Full Text] [Related]
11. Ligand aligning method for molecular docking: alignment of property-weighted vectors.
Joung JY; Nam KY; Cho KH; No KT
J Chem Inf Model; 2012 Apr; 52(4):984-95. PubMed ID: 22471323
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on the use of docking and Bayesian categorization to predict ligand binding to nicotinic acetylcholine receptors (nAChRs) subtypes.
Kombo DC; Bencherif M
J Chem Inf Model; 2013 Dec; 53(12):3212-22. PubMed ID: 24328365
[TBL] [Abstract][Full Text] [Related]
13. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Deniz U; Ozkirimli E; Ulgen KO
J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K
J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662
[TBL] [Abstract][Full Text] [Related]
15. Screening protein-small molecule interactions by NMR.
Davis B
Methods Mol Biol; 2013; 1008():389-413. PubMed ID: 23729260
[TBL] [Abstract][Full Text] [Related]
16. Molecular topology applied to the discovery of 1-benzyl-2-(3-fluorophenyl)-4-hydroxy-3-(3-phenylpropanoyl)-2H-pyrrole-5-one as a non-ligand-binding-pocket antiandrogen.
Caboni L; Gálvez-Llompart M; Gálvez J; Blanco F; Rubio-Martinez J; Fayne D; Lloyd DG
J Chem Inf Model; 2014 Oct; 54(10):2953-66. PubMed ID: 25233256
[TBL] [Abstract][Full Text] [Related]
17. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
[TBL] [Abstract][Full Text] [Related]
18. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
[TBL] [Abstract][Full Text] [Related]
19. SwissParam: a fast force field generation tool for small organic molecules.
Zoete V; Cuendet MA; Grosdidier A; Michielin O
J Comput Chem; 2011 Aug; 32(11):2359-68. PubMed ID: 21541964
[TBL] [Abstract][Full Text] [Related]
20. Identification of new Fyn kinase inhibitors using a FLAP-based approach.
Poli G; Tuccinardi T; Rizzolio F; Caligiuri I; Botta L; Granchi C; Ortore G; Minutolo F; Schenone S; Martinelli A
J Chem Inf Model; 2013 Oct; 53(10):2538-47. PubMed ID: 24001328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
